Back
C4 Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
CCCC
C4 Therapeutics
Last Price:
$2.27
Seasonality Move:
-15.17%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCCC is experiencing selling pressure, which indicates risk of future bearish movement.
C4 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.16 | Buy |
20-day SMA: | 1.77 | Buy |
50-day SMA: | 1.59 | Buy |
200-day SMA: | 3.12 | Sell |
8-day EMA: | 2.1 | Buy |
20-day EMA: | 1.88 | Buy |
50-day EMA: | 1.74 | Buy |
200-day EMA: | 2.85 | Sell |
C4 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 67.05 | Buy |
Chaikin Money Flow: | -2456559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.42 - 2.04) | Buy |
Bollinger Bands (100): | (1.3 - 2.12) | Buy |
C4 Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for C4 Therapeutics Stock
Is C4 Therapeutics Stock a Buy?
-
C4 Therapeutics share price is 2.32 while CCCC 8-day simple moving average is 2.16, which is a Buy signal.
-
The stock price of CCCC is 2.32 while C4 Therapeutics 20-day SMA is 1.77, which makes it a Buy.
-
C4 Therapeutics 50-day simple moving average is 1.59 while CCCC share price is 2.32, making it a Buy technically.
-
CCCC stock price is 2.32 and C4 Therapeutics 200-day simple moving average is 3.12, creating a Sell signal.
CCCC Technical Analysis vs Fundamental Analysis
Buy
57
C4 Therapeutics (CCCC)
is a Buy
Is C4 Therapeutics a Buy or a Sell?
-
C4 Therapeutics stock is rated a BuyThe current C4 Therapeutics [CCCC] share price is $2.32. The Score for CCCC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
C4 Therapeutics Stock Info
Market Cap:
164.7M
Price in USD:
2.32
Share Volume:
4M
C4 Therapeutics 52-Week Range
52-Week High:
7.36
52-Week Low:
1.09
Buy
57
C4 Therapeutics (CCCC)
is a Buy
C4 Therapeutics Share Price Forecast
-
What is the C4 Therapeutics stock price today?The C4 Therapeutics stock price is 2.32 USD today.
-
Will CCCC stock go up or go down?C4 Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is C4 Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, C4 Therapeutics is not overvalued.
Is C4 Therapeutics Stock a Buy?
-
C4 Therapeutics share price is 2.32 while CCCC 8-day exponential moving average is 2.10, which is a Buy signal.
-
The stock price of CCCC is 2.32 while C4 Therapeutics 20-day EMA is 1.88, which makes it a Buy.
-
C4 Therapeutics 50-day exponential moving average is 1.74 while CCCC share price is 2.32, making it a Buy technically.
-
CCCC stock price is 2.32 and C4 Therapeutics 200-day simple moving average is 2.85, creating a Sell signal.
Fundamental Analysis of C4 Therapeutics
Is C4 Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.32 per share, and an increase next year of $0.00 per share.
Technical Analysis of C4 Therapeutics
Should I short C4 Therapeutics stock?
-
CCCC Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting C4 Therapeutics is a Buy
-
C4 Therapeutics Relative Strength Index (RSI) is 67.05, which suggest C4 Therapeutics is overbought
-
The Bollinger Bands (25) for C4 Therapeutics is (1.42 - 2.04), which suggest C4 Therapeutics is a Buy
-
The Bollinger Bands (100) for C4 Therapeutics is (1.3 - 2.12), which suggest C4 Therapeutics is a Buy
* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.